Cargando…
Engineered protein and Jakinib nanoplatform with extraordinary rheumatoid arthritis treatment
Rheumatoid arthritis (RA) is a relatively common inflammatory disease that affects the synovial tissue, eventually results in joints destruction and even long-term disability. Although Janus kinase inhibitors (Jakinibs) show a rapid efficacy and are becoming the most successful agents in RA therapy,...
Autores principales: | Li, Yuanxin, Li, Bo, Wang, Gang, Su, Juanjuan, Qiao, Yilin, Ma, Chao, Wang, Fan, Zhu, Jian, Li, Jingjing, Zhang, Hongjie, Liu, Kai, Xu, Huji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tsinghua University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256963/ https://www.ncbi.nlm.nih.gov/pubmed/37359076 http://dx.doi.org/10.1007/s12274-023-5838-0 |
Ejemplares similares
-
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
por: T. Virtanen, Anniina, et al.
Publicado: (2019) -
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
por: Alexander, Madison, et al.
Publicado: (2021) -
Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitis
por: Seal, Rishav, et al.
Publicado: (2023) -
IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes: JAKinibs suppress the interferon response in RA-FLSs
por: Bonelli, Michael, et al.
Publicado: (2019) -
Inflammation‐Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging‐Guided Therapy of Rheumatoid Arthritis
por: Li, Luoyuan, et al.
Publicado: (2022)